nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—SLC22A7—Fluorouracil—skin cancer	0.199	0.567	CbGbCtD
Minocycline—SLC22A7—Docetaxel—skin cancer	0.152	0.433	CbGbCtD
Minocycline—IL1B—dermis—skin cancer	0.0238	0.0602	CbGeAlD
Minocycline—MMP9—dermis—skin cancer	0.0198	0.0502	CbGeAlD
Minocycline—IL1B—leg—skin cancer	0.0157	0.0397	CbGeAlD
Minocycline—IL1B—forelimb—skin cancer	0.0156	0.0394	CbGeAlD
Minocycline—CASP3—appendage—skin cancer	0.0151	0.0381	CbGeAlD
Minocycline—IL1B—hindlimb—skin cancer	0.014	0.0355	CbGeAlD
Minocycline—CASP3—skin epidermis—skin cancer	0.0125	0.0317	CbGeAlD
Minocycline—IL1B—appendage—skin cancer	0.012	0.0304	CbGeAlD
Minocycline—MMP9—hindlimb—skin cancer	0.0117	0.0296	CbGeAlD
Minocycline—CASP3—nerve—skin cancer	0.0107	0.027	CbGeAlD
Minocycline—CYCS—Sorafenib—Vismodegib—skin cancer	0.0103	1	CbGdCrCtD
Minocycline—MMP9—appendage—skin cancer	0.01	0.0254	CbGeAlD
Minocycline—IL1B—skin epidermis—skin cancer	0.01	0.0253	CbGeAlD
Minocycline—CYCS—blood vessel—skin cancer	0.0098	0.0248	CbGeAlD
Minocycline—CASP3—endothelium—skin cancer	0.0091	0.023	CbGeAlD
Minocycline—CASP3—blood vessel—skin cancer	0.00839	0.0212	CbGeAlD
Minocycline—MMP9—skin epidermis—skin cancer	0.00835	0.0211	CbGeAlD
Minocycline—CASP1—nipple—skin cancer	0.00736	0.0186	CbGeAlD
Minocycline—IL1B—endothelium—skin cancer	0.00727	0.0184	CbGeAlD
Minocycline—CYCS—neck—skin cancer	0.00701	0.0177	CbGeAlD
Minocycline—IL1B—blood vessel—skin cancer	0.0067	0.0169	CbGeAlD
Minocycline—CASP3—nipple—skin cancer	0.00607	0.0153	CbGeAlD
Minocycline—MMP9—endothelium—skin cancer	0.00606	0.0153	CbGeAlD
Minocycline—CASP3—neck—skin cancer	0.006	0.0152	CbGeAlD
Minocycline—MMP9—blood vessel—skin cancer	0.00559	0.0141	CbGeAlD
Minocycline—CASP1—connective tissue—skin cancer	0.00522	0.0132	CbGeAlD
Minocycline—CYCS—connective tissue—skin cancer	0.00502	0.0127	CbGeAlD
Minocycline—CASP1—epithelium—skin cancer	0.00495	0.0125	CbGeAlD
Minocycline—CYCS—epithelium—skin cancer	0.00477	0.0121	CbGeAlD
Minocycline—CASP1—skin of body—skin cancer	0.00471	0.0119	CbGeAlD
Minocycline—CYCS—skin of body—skin cancer	0.00454	0.0115	CbGeAlD
Minocycline—CASP3—connective tissue—skin cancer	0.0043	0.0109	CbGeAlD
Minocycline—CASP1—mammalian vulva—skin cancer	0.0043	0.0109	CbGeAlD
Minocycline—CASP3—epithelium—skin cancer	0.00408	0.0103	CbGeAlD
Minocycline—MMP9—neck—skin cancer	0.004	0.0101	CbGeAlD
Minocycline—CASP3—skin of body—skin cancer	0.00389	0.00982	CbGeAlD
Minocycline—CASP1—lymphoid tissue—skin cancer	0.00382	0.00964	CbGeAlD
Minocycline—CASP1—female reproductive system—skin cancer	0.00368	0.0093	CbGeAlD
Minocycline—CYCS—lymphoid tissue—skin cancer	0.00367	0.00928	CbGeAlD
Minocycline—CASP3—mammalian vulva—skin cancer	0.00354	0.00896	CbGeAlD
Minocycline—CYCS—female reproductive system—skin cancer	0.00354	0.00895	CbGeAlD
Minocycline—IL1B—connective tissue—skin cancer	0.00344	0.00869	CbGeAlD
Minocycline—IL1B—epithelium—skin cancer	0.00326	0.00825	CbGeAlD
Minocycline—CASP3—lymphoid tissue—skin cancer	0.00315	0.00795	CbGeAlD
Minocycline—IL1B—skin of body—skin cancer	0.0031	0.00784	CbGeAlD
Minocycline—CASP1—head—skin cancer	0.00307	0.00777	CbGeAlD
Minocycline—CASP3—female reproductive system—skin cancer	0.00303	0.00767	CbGeAlD
Minocycline—CYCS—head—skin cancer	0.00296	0.00748	CbGeAlD
Minocycline—MMP9—connective tissue—skin cancer	0.00286	0.00724	CbGeAlD
Minocycline—VEGFA—mammalian vulva—skin cancer	0.00278	0.00704	CbGeAlD
Minocycline—MMP9—epithelium—skin cancer	0.00272	0.00687	CbGeAlD
Minocycline—MMP9—skin of body—skin cancer	0.00259	0.00654	CbGeAlD
Minocycline—CASP3—head—skin cancer	0.00254	0.00641	CbGeAlD
Minocycline—IL1B—lymphoid tissue—skin cancer	0.00251	0.00635	CbGeAlD
Minocycline—IL1B—female reproductive system—skin cancer	0.00242	0.00613	CbGeAlD
Minocycline—ALOX5—connective tissue—skin cancer	0.00226	0.00572	CbGeAlD
Minocycline—CASP1—lymph node—skin cancer	0.00215	0.00544	CbGeAlD
Minocycline—MMP9—lymphoid tissue—skin cancer	0.00209	0.00529	CbGeAlD
Minocycline—CYCS—lymph node—skin cancer	0.00207	0.00524	CbGeAlD
Minocycline—IL1B—head—skin cancer	0.00203	0.00512	CbGeAlD
Minocycline—MMP9—female reproductive system—skin cancer	0.00202	0.00511	CbGeAlD
Minocycline—SLC22A11—female reproductive system—skin cancer	0.00192	0.00484	CbGeAlD
Minocycline—CASP3—lymph node—skin cancer	0.00178	0.00449	CbGeAlD
Minocycline—MMP9—head—skin cancer	0.00169	0.00427	CbGeAlD
Minocycline—ALOX5—lymphoid tissue—skin cancer	0.00166	0.00419	CbGeAlD
Minocycline—ALOX5—female reproductive system—skin cancer	0.0016	0.00404	CbGeAlD
Minocycline—IL1B—lymph node—skin cancer	0.00142	0.00358	CbGeAlD
Minocycline—VEGFA—lymph node—skin cancer	0.00139	0.00353	CbGeAlD
Minocycline—ALOX5—head—skin cancer	0.00133	0.00337	CbGeAlD
Minocycline—MMP9—lymph node—skin cancer	0.00118	0.00299	CbGeAlD
Minocycline—ALOX5—lymph node—skin cancer	0.000934	0.00236	CbGeAlD
Minocycline—SLC22A8—head—skin cancer	0.000903	0.00228	CbGeAlD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000639	0.00264	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CDK4—skin cancer	0.000623	0.00257	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—skin cancer	0.000621	0.00256	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—PTGS2—skin cancer	0.000619	0.00256	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—IL6—skin cancer	0.000619	0.00255	CbGpPWpGaD
Minocycline—SLC22A7—Fluoropyrimidine Activity—TP53—skin cancer	0.000617	0.00255	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—TP53—skin cancer	0.000615	0.00254	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—skin cancer	0.000613	0.00253	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—SCN10A—skin cancer	0.000611	0.00252	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FOXO4—skin cancer	0.000611	0.00252	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.00061	0.00252	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—NRAS—skin cancer	0.000609	0.00251	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—BRAF—skin cancer	0.000598	0.00247	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—HRAS—skin cancer	0.000595	0.00246	CbGpPWpGaD
Minocycline—VEGFA—VEGFR2 mediated cell proliferation—HRAS—skin cancer	0.000595	0.00246	CbGpPWpGaD
Minocycline—CASP3—DNA Damage Response—TP53—skin cancer	0.000593	0.00245	CbGpPWpGaD
Minocycline—MMP9—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	0.00059	0.00244	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—HRAS—skin cancer	0.000588	0.00243	CbGpPWpGaD
Minocycline—CASP3—p75(NTR)-mediated signaling—TP53—skin cancer	0.000586	0.00242	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CDK4—skin cancer	0.000584	0.00241	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—TP53—skin cancer	0.000582	0.0024	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—PTGS2—skin cancer	0.00058	0.0024	CbGpPWpGaD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—TP53—skin cancer	0.000573	0.00237	CbGpPWpGaD
Minocycline—VEGFA—VEGFR2 mediated cell proliferation—IL6—skin cancer	0.00057	0.00235	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—HRAS—skin cancer	0.000567	0.00234	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—RASA1—skin cancer	0.000566	0.00234	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—IL6—skin cancer	0.000554	0.00229	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000553	0.00228	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TP53—skin cancer	0.00055	0.00227	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.00055	0.00227	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—NRAS—skin cancer	0.000545	0.00225	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—IL6—skin cancer	0.000543	0.00224	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—BRAF—skin cancer	0.000542	0.00224	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RHOU—skin cancer	0.000537	0.00222	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—NRAS—skin cancer	0.000531	0.00219	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PLIN2—skin cancer	0.000527	0.00217	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TP53—skin cancer	0.000526	0.00217	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—KRAS—skin cancer	0.000524	0.00216	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—IL6—skin cancer	0.000503	0.00208	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000502	0.00207	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—skin cancer	0.000501	0.00207	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—RASA1—skin cancer	0.000491	0.00203	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—NRAS—skin cancer	0.000485	0.002	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TP53—skin cancer	0.000482	0.00199	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TP53—skin cancer	0.000476	0.00197	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—HRAS—skin cancer	0.000475	0.00196	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TP53—skin cancer	0.00047	0.00194	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—KRAS—skin cancer	0.000469	0.00193	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000467	0.00193	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RHOU—skin cancer	0.000466	0.00193	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—KRAS—skin cancer	0.000457	0.00189	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CDKN2A—skin cancer	0.000446	0.00184	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—HRAS—skin cancer	0.000445	0.00184	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—PTGS2—skin cancer	0.000445	0.00184	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CDK4—skin cancer	0.000444	0.00183	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000436	0.0018	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—IL6—skin cancer	0.000432	0.00178	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR7—skin cancer	0.000431	0.00178	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—IL6—skin cancer	0.000426	0.00176	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CSPG4—skin cancer	0.000425	0.00175	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000422	0.00174	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—KRAS—skin cancer	0.000417	0.00172	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—KRAS—skin cancer	0.000417	0.00172	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—skin cancer	0.000417	0.00172	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—HRAS—skin cancer	0.000413	0.00171	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—HRAS—skin cancer	0.00041	0.00169	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—RASA1—skin cancer	0.000404	0.00167	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—skin cancer	0.000402	0.00166	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—IL6—skin cancer	0.0004	0.00165	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—BRAF—skin cancer	0.000393	0.00162	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—IL6—skin cancer	0.000393	0.00162	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—BRAF—skin cancer	0.000391	0.00161	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—HRAS—skin cancer	0.000388	0.0016	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—skin cancer	0.000382	0.00158	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—skin cancer	0.00038	0.00157	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—skin cancer	0.000379	0.00157	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTCH2—skin cancer	0.000378	0.00156	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—NRAS—skin cancer	0.000376	0.00155	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL6—skin cancer	0.000372	0.00153	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—skin cancer	0.000371	0.00153	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL6—skin cancer	0.000368	0.00152	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000368	0.00152	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—skin cancer	0.000365	0.00151	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—HRAS—skin cancer	0.000363	0.0015	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—NRAS—skin cancer	0.000362	0.00149	CbGpPWpGaD
Minocycline—CASP1—Immune System—FOXO4—skin cancer	0.000356	0.00147	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.000355	0.00147	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—HRAS—skin cancer	0.000355	0.00146	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—HRAS—skin cancer	0.000354	0.00146	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—KRAS—skin cancer	0.000353	0.00146	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000352	0.00145	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—RASA1—skin cancer	0.000351	0.00145	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL6—skin cancer	0.000349	0.00144	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IL6—skin cancer	0.000347	0.00143	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—skin cancer	0.000345	0.00143	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—NRAS—skin cancer	0.00034	0.0014	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL6—skin cancer	0.000339	0.0014	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL6—skin cancer	0.000337	0.00139	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—BRAF—skin cancer	0.000327	0.00135	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—NRAS—skin cancer	0.000325	0.00134	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PLIN2—skin cancer	0.000325	0.00134	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—KRAS—skin cancer	0.000324	0.00134	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL6—skin cancer	0.000316	0.00131	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—skin cancer	0.000313	0.00129	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—KRAS—skin cancer	0.000311	0.00129	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—HRAS—skin cancer	0.000311	0.00128	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—NRAS—skin cancer	0.000307	0.00127	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—skin cancer	0.000307	0.00127	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—HRAS—skin cancer	0.000304	0.00125	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—NRAS—skin cancer	0.0003	0.00124	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—KRAS—skin cancer	0.000293	0.00121	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000292	0.00121	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ENO2—skin cancer	0.000289	0.00119	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—skin cancer	0.000288	0.00119	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GLI2—skin cancer	0.000286	0.00118	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDK4—skin cancer	0.000284	0.00117	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—KRAS—skin cancer	0.00028	0.00116	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—skin cancer	0.000279	0.00115	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	0.000277	0.00114	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MC1R—skin cancer	0.000273	0.00113	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GLI1—skin cancer	0.000269	0.00111	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—skin cancer	0.000265	0.00109	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HRAS—skin cancer	0.000265	0.00109	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—KRAS—skin cancer	0.000264	0.00109	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—HRAS—skin cancer	0.000264	0.00109	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000263	0.00108	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTCH2—skin cancer	0.000262	0.00108	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CSPG4—skin cancer	0.000262	0.00108	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—skin cancer	0.00026	0.00107	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.00026	0.00107	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—KRAS—skin cancer	0.000259	0.00107	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SUFU—skin cancer	0.000255	0.00105	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000254	0.00105	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—skin cancer	0.000253	0.00105	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—skin cancer	0.000253	0.00104	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—skin cancer	0.000248	0.00103	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—NRAS—skin cancer	0.000246	0.00101	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL6—skin cancer	0.000243	0.001	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—HRAS—skin cancer	0.000238	0.000982	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTCH2—skin cancer	0.000228	0.00094	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—skin cancer	0.000228	0.00094	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—skin cancer	0.000227	0.000938	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—NRAS—skin cancer	0.000226	0.000934	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—HRAS—skin cancer	0.000225	0.000927	CbGpPWpGaD
Minocycline—IL1B—Immune System—FOXO4—skin cancer	0.000222	0.000917	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—HRAS—skin cancer	0.00022	0.000907	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN2A—skin cancer	0.000217	0.000896	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—skin cancer	0.000215	0.000887	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—KRAS—skin cancer	0.000212	0.000877	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—KRAS—skin cancer	0.000211	0.000873	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—skin cancer	0.00021	0.000868	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—NRAS—skin cancer	0.000203	0.000838	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GLI2—skin cancer	0.000199	0.000821	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CDK4—skin cancer	0.000198	0.000818	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SHH—skin cancer	0.000195	0.000804	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—KRAS—skin cancer	0.000195	0.000804	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RASA1—skin cancer	0.000194	0.000799	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MC1R—skin cancer	0.00019	0.000783	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—skin cancer	0.000189	0.000779	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GLI1—skin cancer	0.000187	0.000772	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTCH1—skin cancer	0.000185	0.000762	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SMO—skin cancer	0.000185	0.000762	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—HRAS—skin cancer	0.00018	0.000742	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTGER4—skin cancer	0.00018	0.000742	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ENO2—skin cancer	0.000178	0.000734	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SUFU—skin cancer	0.000177	0.000732	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	0.000176	0.000727	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—KRAS—skin cancer	0.000175	0.000721	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GLI2—skin cancer	0.000173	0.000713	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—skin cancer	0.000172	0.00071	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CDK4—skin cancer	0.000172	0.00071	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—skin cancer	0.000168	0.000695	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ERCC2—skin cancer	0.000168	0.000692	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HRAS—skin cancer	0.000165	0.000683	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MC1R—skin cancer	0.000165	0.00068	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GLI1—skin cancer	0.000162	0.00067	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FOXO4—skin cancer	0.000159	0.000655	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—skin cancer	0.000158	0.000654	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	0.000156	0.000646	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—NRAS—skin cancer	0.000154	0.000637	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SUFU—skin cancer	0.000154	0.000635	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—HRAS—skin cancer	0.00015	0.00062	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HRAS—skin cancer	0.000148	0.000613	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—skin cancer	0.000142	0.000587	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000139	0.000574	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SHH—skin cancer	0.000135	0.000558	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RASA1—skin cancer	0.000134	0.000555	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—NRAS—skin cancer	0.000134	0.000553	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—KRAS—skin cancer	0.000133	0.000548	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMO—skin cancer	0.000128	0.000529	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTCH1—skin cancer	0.000128	0.000529	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTGER4—skin cancer	0.000125	0.000515	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—skin cancer	0.000121	0.000498	CbGpPWpGaD
Minocycline—CASP1—Immune System—NRAS—skin cancer	0.000118	0.000488	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SHH—skin cancer	0.000117	0.000484	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RASA1—skin cancer	0.000117	0.000481	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—KRAS—skin cancer	0.000115	0.000476	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—HRAS—skin cancer	0.000113	0.000466	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTCH1—skin cancer	0.000111	0.000459	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMO—skin cancer	0.000111	0.000459	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—skin cancer	0.000111	0.000456	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FOXO4—skin cancer	0.00011	0.000455	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NRAS—skin cancer	0.00011	0.000455	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTGER4—skin cancer	0.000108	0.000447	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—skin cancer	0.000108	0.000446	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TERT—skin cancer	0.000106	0.000438	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ERCC2—skin cancer	0.000103	0.000426	CbGpPWpGaD
Minocycline—CASP1—Immune System—KRAS—skin cancer	0.000102	0.00042	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—skin cancer	0.000101	0.000415	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—HRAS—skin cancer	9.8e-05	0.000405	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FOXO4—skin cancer	9.57e-05	0.000395	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NRAS—skin cancer	9.56e-05	0.000395	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—KRAS—skin cancer	9.48e-05	0.000391	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—skin cancer	9.38e-05	0.000387	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NRAS—skin cancer	9.38e-05	0.000387	CbGpPWpGaD
Minocycline—CASP1—Immune System—HRAS—skin cancer	8.65e-05	0.000357	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—BRAF—skin cancer	8.4e-05	0.000347	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—skin cancer	8.28e-05	0.000342	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—KRAS—skin cancer	8.23e-05	0.00034	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—KRAS—skin cancer	8.07e-05	0.000333	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HRAS—skin cancer	8.06e-05	0.000333	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—skin cancer	7.71e-05	0.000318	CbGpPWpGaD
Minocycline—IL1B—Immune System—NRAS—skin cancer	7.39e-05	0.000305	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TERT—skin cancer	7.36e-05	0.000304	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—skin cancer	7.18e-05	0.000296	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HRAS—skin cancer	7e-05	0.000289	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HRAS—skin cancer	6.86e-05	0.000283	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—skin cancer	6.7e-05	0.000276	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TERT—skin cancer	6.39e-05	0.000264	CbGpPWpGaD
Minocycline—IL1B—Immune System—KRAS—skin cancer	6.36e-05	0.000262	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—skin cancer	6.19e-05	0.000256	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BRAF—skin cancer	5.83e-05	0.000241	CbGpPWpGaD
Minocycline—IL1B—Immune System—HRAS—skin cancer	5.4e-05	0.000223	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NRAS—skin cancer	5.28e-05	0.000218	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—skin cancer	5.17e-05	0.000214	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BRAF—skin cancer	5.06e-05	0.000209	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KRAS—skin cancer	4.54e-05	0.000187	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—skin cancer	4.04e-05	0.000167	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HRAS—skin cancer	3.86e-05	0.000159	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—skin cancer	3.7e-05	0.000153	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NRAS—skin cancer	3.66e-05	0.000151	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NRAS—skin cancer	3.18e-05	0.000131	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KRAS—skin cancer	3.15e-05	0.00013	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—skin cancer	2.8e-05	0.000116	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KRAS—skin cancer	2.74e-05	0.000113	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HRAS—skin cancer	2.68e-05	0.000111	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—skin cancer	2.57e-05	0.000106	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—skin cancer	2.43e-05	0.0001	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HRAS—skin cancer	2.33e-05	9.6e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—skin cancer	2.23e-05	9.19e-05	CbGpPWpGaD
